ArticleProceedings of the National Academy of Sciences of the United States of America2026
Natalizumab exacerbates astrocytopathy in NMOSD via blockade of endothelial VCAM1-astrocytic integrin α4 interaction.
Tingting Cui et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.